1. Clinical Utility of Chromosomal Aneusomy in Individuals at High Risk of Lung Cancer 
Anna E. Barón, PhD, Severine Kako, BS, William J. Feser, MS, Heather Malinowski, BS, Daniel Merrick, MD, Kavita Garg, MD, Stephen Malkoski, MD, PhD, Shannon Pretzel, BA, Jill M. Siegfried, PhD, Wilbur A. Franklin, PhD, York Miller, MD, Holly J. Wolf, MSPH, PhD, Marileila Varella-Garcia, PhD 
Journal of Thoracic Oncology 
Volume 12, Issue 10, Pages (October 2017)
DOI: /j.jtho
Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions

2. Figure 1
Scoring criteria and illustration of the four-category scale used for the assay determining chromosomal aneusomy in sputum by fluorescence in situ hybridization. CNG, copy number gain.
Journal of Thoracic Oncology  , DOI: ( /j.jtho )
Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions

3. Figure 2
Receiver operating characteristic curves and areas under the curve (AUC) for assay determining chromosomal aneusomy in sputum by fluorescence in situ hybridization, by nested case-control study cohort. CO High-Risk, Colorado High-Risk Cohort; CO Nodule; Colorado Nodule Cohort; PLuSS, Pittsburgh Lung Screening Study; ACRIN/NLST, American College of Radiology Imaging Network/National Lung Screening Trial.
Journal of Thoracic Oncology  , DOI: ( /j.jtho )
Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions